Michael Feehan
Insider
First SEC filing: Aug. 13, 2021 · Latest: Aug. 13, 2021
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | ECVT | A | 11,052 | $11.31 | $124,998 | 389,071 Direct | +2.92% | Acquired | -10.5% (price as of 2026-10-02) |
| Feb. 3, 2026 | ECVT | F | 4,834 | $10.31 | $49,839 | 358,620 Direct | -1.33% | Disposed | -1.8% (price as of 2026-10-02) |
| Feb. 3, 2026 | ECVT | A | 19,399 | · | · | 378,019 Direct | +5.41% | Acquired | (price as of 2026-10-02) |
| Jan. 22, 2026 | ECVT | F | 4,246 | $10.84 | $46,027 | 363,454 Direct | -1.15% | Disposed | -6.6% (price as of 2026-10-02) |
| Jan. 5, 2026 | ECVT | F | 6,231 | $9.80 | $61,064 | 367,700 Direct | -1.67% | Disposed | 3.3% (price as of 2026-10-02) |
| Feb. 3, 2025 | ECVT | A | 25,674 | · | · | 373,931 Direct | +7.37% | Acquired | (price as of 2026-10-02) |
| Jan. 22, 2025 | ECVT | F | 2,382 | $7.96 | $18,961 | 348,257 Direct | -0.68% | Disposed | 27.1% (price as of 2026-10-02) |
| Jan. 5, 2025 | ECVT | F | 14,160 | $7.76 | $109,882 | 350,639 Direct | -3.88% | Disposed | 30.4% (price as of 2026-10-02) |
| Aug. 5, 2024 | ECVT | P | 16,000 | $6.28 | $100,480 | 364,799 Direct | +4.59% | Acquired | 61.1% (price as of 2026-10-02) |
| Jan. 22, 2024 | ECVT | A | 22,702 | · | · | 348,799 Direct | +6.96% | Acquired | (price as of 2026-10-02) |
| Jan. 5, 2024 | ECVT | F | 14,843 | $9.46 | $140,415 | 326,097 Direct | -4.35% | Disposed | 7.0% (price as of 2026-10-02) |
| Aug. 23, 2023 | ECVT | P | 5,000 | $9.67 | $48,350 | 340,940 Direct | +1.49% | Acquired | 4.7% (price as of 2026-10-02) |
| July 1, 2023 | ECVT | F | 75,058 | $11.37 | $853,409 | 335,940 Direct | -18.26% | Disposed | -11.0% (price as of 2026-10-02) |
| March 8, 2023 | ECVT | A | 2,872 | · | · | 410,998 Direct | +0.70% | Acquired | (price as of 2026-10-02) |
| March 7, 2023 | ECVT | D | 13,586 | · | · | 408,126 Direct | -3.22% | Disposed | (price as of 2026-10-02) |
| Jan. 16, 2023 | ECVT | A | 50,813 | · | · | 421,712 Direct | +13.70% | Acquired | (price as of 2026-10-02) |
| Jan. 5, 2023 | ECVT | F | 8,180 | $9.04 | $73,947 | 370,899 Direct | -2.16% | Disposed | 11.9% (price as of 2026-10-02) |
| Nov. 16, 2022 | ECVT | M | 6,620 | · | · | 6,621 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| Nov. 16, 2022 | ECVT | M | 6,620 | $3.98 | $26,348 | 379,079 Direct | +1.78% | Acquired | 154.3% (price as of 2026-10-02) |
| Aug. 4, 2022 | ECVT | P | 11,425 | $8.77 | $100,197 | 372,459 Direct | +3.16% | Acquired | 15.4% (price as of 2026-10-02) |
| May 19, 2022 | ECVT | P | 5,000 | $9.96 | $49,800 | 361,034 Direct | +1.40% | Acquired | 1.6% (price as of 2026-10-02) |
| March 1, 2022 | ECVT | A | 8,112 | · | · | 356,034 Direct | +2.33% | Acquired | (price as of 2026-10-02) |
| Jan. 17, 2022 | ECVT | A | 145,773 | · | · | 347,922 Direct | +72.11% | Acquired | (price as of 2026-10-02) |
| Jan. 17, 2022 | ECVT | A | 72,887 | · | · | 202,149 Direct | +56.39% | Acquired | (price as of 2026-10-02) |
| Jan. 5, 2022 | ECVT | F | 901 | $10.27 | $9,253 | 129,262 Direct | -0.69% | Disposed | -1.5% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 16, 2022 | ECVT | Stock Option (right to buy) | Common Stock | $3.98 | Jan. 15, 2027 | 6,620 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.